BAMCO INC /NY/ - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 146 filers reported holding DICERNA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 3.99 and the average weighting 0.4%.

Quarter-by-quarter ownership
BAMCO INC /NY/ ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$1,297,000
+45.9%
34,7620.0%0.00%
+50.0%
Q1 2021$889,000
+6.3%
34,762
-8.4%
0.00%0.0%
Q4 2020$836,000
+307.8%
37,962
+232.9%
0.00%
+100.0%
Q3 2020$205,000
+25.8%
11,405
+78.1%
0.00%0.0%
Q2 2020$163,000
+38.1%
6,4050.0%0.00%0.0%
Q1 2020$118,000
+84.4%
6,405
+120.9%
0.00%
Q4 2019$64,0002,9000.00%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 1,355,392$29,859,0006.21%
Bain Capital Life Sciences Investors, LLC 3,080,237$67,858,0004.26%
DAFNA Capital Management LLC 587,756$12,948,0003.85%
SILVERARC CAPITAL MANAGEMENT, LLC 227,388$5,009,0002.91%
RTW INVESTMENTS, LP 7,253,857$159,802,0002.68%
Parkman Healthcare Partners LLC 331,513$7,303,0001.87%
Evolutionary Tree Capital Management, LLC 60,864$1,341,0001.02%
Eagle Health Investments LP 69,000$1,520,0000.97%
Woodline Partners LP 1,358,796$29,934,0000.79%
Affinity Asset Advisors, LLC 40,000$881,0000.47%
View complete list of DICERNA PHARMACEUTICALS INC shareholders